Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Arbutus Biopharma Corp changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 127 | 114 | −13 |
| Shares | 46.6M | 54.2M | +7.60M (+16.3%) |
| Value | $89.1M | $126.3M | +$37.2M (+41.8%) |
New holders (11)
Institutions that held Arbutus Biopharma Corp at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Whitefort Capital Management, LP | 3,850,769 | $8.97M | 6.97% |
| Rubric Capital Management LP | 3,466,281 | $8.08M | 0.35% |
| Tejara Capital Ltd | 200,000 | $466.0K | 0.27% |
| Clear Harbor Asset Management, LLC | 53,000 | $123.5K | 0.02% |
| Virtu Financial LLC | 44,194 | $103.0K | 0.01% |
| UBS Group AG | 23,289 | $54.3K | 0.00% |
| Kades & Cheifetz LLC | 20,000 | $46.6K | 0.04% |
| Squarepoint Ops LLC | 13,650 | $31.8K | 0.00% |
| Alpine Global Management, LLC | 10,198 | $24.0K | 0.01% |
| Allworth Financial LP | 440 | $1.02K | 0.00% |
| GWM Advisors LLC | 10 | $0 | 0.00% |
Sold out (24)
Institutions that held Arbutus Biopharma Corp at the end of Q3 2022 and filed for Q4 2022 without it.